MARKET WRAP: Aspen boosts JSE as J&J vaccine rollout set to resume
The all share was up 0.41% and the top 40 0.39%
26 April 2021 - 19:04
Aspen Pharmacare was the star performer on the JSE after a broker upgrade and the resumption of the rollout of the vaccine it is preparing for Johnson & Johnson (J&J) at its plant in the Eastern Cape.
“We have secured enough doses to vaccinate at least 45-million people in SA ... I am therefore thrilled that the first 1.1-million doses of J&J Covid-19 vaccines are ready for dispatch from the Gqeberha plant,” health minister Zweli Mkhize said on Monday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.